First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: The approval of an mRNA-based flu vaccine by the FDA is likely to impact public health initiatives and vaccine distribution efforts across New Jersey. This new technology could influence vaccination rates and public health messaging from agencies like the Bergen County Department of Public Safety / Emergency Management.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.